SCHEMBL3942565

SCHEMBL3942565

CS(=O)(=O)c1ccc(S(=O)(=O)Nc2ccc3[nH]c(OC(=O)Nc4ccccc4)c(-c4ccccc4)c3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.44
HTR6 P50406 1/20 0.44
BRD4 O60885 3/20 0.43
AURKA O14965 8/20 0.43
AURKB Q96GD4 6/20 0.43
IMPDH2 P12268 1/20 0.43
MEN1 O00255 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
SERPINE1 P05121 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3947000 0.91 ITGA1 (0.46) PTGS2BRD4AURKAAURKBSERPINE1
SCHEMBL3945365 0.90 BRD4 (0.55) BRD4AURKAAURKBMEN1KMT2A
SCHEMBL3948051 0.88 GPR27 (0.46) HTR6BRD4AURKAAURKBSERPINE1
SCHEMBL3942914 0.87 HTR6 (0.41) PTGS2HTR6BRD4AURKAAURKB
SCHEMBL3948032 0.87 SERPINE1 (0.55) HTR6BRD4AURKAAURKBSERPINE1
SCHEMBL3947998 0.86 BRD4 (0.52) BRD4MEN1KMT2ASERPINE1
SCHEMBL3951295 0.86 BRD4 (0.52) HTR6BRD4AURKAAURKBMEN1
SCHEMBL3942384 0.85 BRD4 (0.52) BRD4AURKAAURKBMEN1KMT2A
SCHEMBL3943378 0.85 BRD4 (0.52) BRD4MEN1KMT2ASERPINE1
SCHEMBL3944674 0.85 BRD4 (0.52) BRD4MEN1KMT2ASERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802572-B1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AG (DE) 2009-04-22 EP disclosed
EP-1802572-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE Bayer Schering Pharma Aktiengesellschaft (DE) 2007-07-04 EP disclosed
WO-2006032541-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-03-30 WO disclosed